Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  2,239 results for ""Warfarin therapeutic use""

Your Filters

Subject : stroke
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comparing DOAC and warfarin outcomes in an obese population using the 'real-world' Michigan Anticoagulation Quality Improvement Initiative (MAQI 2 ) registry.

  • Authors : Ardeshna N; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.; Current: Department of Cardiology, Rush University Medical Center, Chicago, IL, USA.

Subjects: Registries* ; Warfarin*/Warfarin*/Warfarin*/adverse effects ; Warfarin*/Warfarin*/Warfarin*/therapeutic use

  • Source: Vascular medicine (London, England) [Vasc Med] 2024 Oct; Vol. 29 (5), pp. 543-552. Date of Electronic Publication: 2024 Aug 23.Publisher: SAGE Publications Country of Publication: England NLM ID: 9610930 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of oral anticoagulants for stroke prevention in atrial fibrillation using the UK clinical practice research Datalink Aurum: A reference trial (ARISTOTLE) emulation study.

  • Authors : Powell EM; Department of Non-communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Gungabissoon U

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/complications ; Warfarin*/Warfarin*/Warfarin*/therapeutic use

  • Source: PLoS medicine [PLoS Med] 2024 Aug 29; Vol. 21 (8), pp. e1004377. Date of Electronic Publication: 2024 Aug 29 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Risk of Major Bleeding, Stroke/Systemic Embolism, and Death Associated With Different Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease.

  • Authors : Xu Y; Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore MD USA.; Ballew SH

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/complications ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/mortality

  • Source: Journal of the American Heart Association [J Am Heart Assoc] 2024 Aug 20; Vol. 13 (16), pp. e034641. Date of Electronic Publication: 2024 Aug 09.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims.

  • Authors : Lip GYH; Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK. .; Danish Center for Clinical Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. .

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/complications ; Warfarin*/Warfarin*/Warfarin*/adverse effects

  • Source: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2024 Aug; Vol. 57 (6), pp. 1092-1102. Date of Electronic Publication: 2024 May 02.Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9502018 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Factor Xa Inhibitors versus warfarin in patients with morbid obesity and atrial fibrillation.

  • Authors : Dobry P; Department of Pharmacy, Ascension St. John Hospital, Detroit, MI, USA.; Department of Pharmacy Practice, Wayne State University, Detroit, MI, USA.

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/therapeutic use ; Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/adverse effects

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Jul; Vol. 80 (7), pp. 1039-1050. Date of Electronic Publication: 2024 Mar 20.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

Read More Add to Saved list
×
Academic Journal

Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis.

  • Authors : Harrington J; Duke Clinical Research Institute, Duke University Durham NC USA.; Division of Cardiology, Department of Medicine Duke University School of Medicine Durham NC USA.

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/complications ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/diagnosis

  • Source: Journal of the American Heart Association [J Am Heart Assoc] 2024 Jun 04; Vol. 13 (11), pp. e028951. Date of Electronic Publication: 2024 May 23.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Cost-Effectiveness and Budget Impact Analysis of Apixaban and Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation (NVAF) in Iran.

  • Authors : Tajik A; School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.; Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/complications ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/economics

  • Source: Clinical cardiology [Clin Cardiol] 2024 Jun; Vol. 47 (6), pp. e24311.Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 7903272 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparative Safety and Effectiveness of Reduced Doses of Direct Acting Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation.

  • Authors : Skjøth F; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark; Research Data and Biostatistics, Aalborg University Hospital, Aalborg, Denmark.

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/complications ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Rivaroxaban*/Rivaroxaban*/Rivaroxaban*/therapeutic use

  • Source: The American journal of medicine [Am J Med] 2024 Jun; Vol. 137 (6), pp. 520-528.e13. Date of Electronic Publication: 2024 Feb 21.Publisher: Excerpta Medica Country of Publication: United States NLM ID: 0267200 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Direct oral anticoagulants compared with other strategies in patients with atrial fibrillation and stroke or transient ischemic attack: Systematic review.

  • Authors : Lee KH; Department of Neurology, Chang Gung University College of Medicine, Chang Gung Memorial Hospital, Chiayi Branch, Chiayi, Taiwan.; Hung WT

Subjects: Ischemic Attack, Transient*/Ischemic Attack, Transient*/Ischemic Attack, Transient*/prevention & control ; Ischemic Attack, Transient*/Ischemic Attack, Transient*/Ischemic Attack, Transient*/drug therapy ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy

  • Source: Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2024 May; Vol. 123 (5), pp. 551-560. Date of Electronic Publication: 2023 Oct 12.Publisher: Formosan Medical Association, Elsevier Country of Publication: Singapore NLM ID: 9214933 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic Review and Meta-analysis.

  • Authors : Elshafei MN; Clinical Pharmacy Department, Hamad Medical Corporation, Doha, Qatar. .; Department of Pharmacy, Hamad Medical Corporation (HMC), P.O.3050, Doha, Qatar. .

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/complications ; Warfarin*/Warfarin*/Warfarin*/adverse effects

  • Source: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2024 Mar; Vol. 24 (2), pp. 255-271. Date of Electronic Publication: 2024 Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  2,239 results for ""Warfarin therapeutic use""